Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
aNPC in Degenerative Disc Disease
NCT07168603Phase 2Recruiting
- Sponsor
- ASTEROGENE
- Start
- Sep 2025
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
A Phase 2 trial of autologous nucleus pulposus cells in degenerative disc disease (DDD), sponsored by ASTEROGENE. Started Sep 2025; status: recruiting.
02
Drugs
autologous nucleus pulposus cells
03
Conditions
degenerative disc disease (DDD)
Beyond the preview
Go deeper on NCT07168603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07168603.